Cancer looms large in the public imagination because it can strike down young people in their prime. With more than 3 million new cases and 1.7 million deaths each year, it represents the second most important cause of death and illness in Europe, after cardio-vascular disease. New, more targeted treatments are emerging and a significant proportion of cancers can be cured or at least their progression can be slowed, especially if they are detected early. IMI has funded a number of cancer projects, and is expected to play a significant role of the European Commission's cancer mission, as part of the next research programme, Horizon Europe.
New cancer therapies offer hope, but there’s still a lot we don’t know
First batch of real-world data from prostate cancer studies added to big data platform
CANCER-ID hunts for cancer clues in blood samples
The secret life of tumours - where IMI cancer research is headed